SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: December 28, 1994
C. R. Bard, Inc.
(EXACT NAME OF REGISTRANT AS
SPECIFIED IN ITS CHARTER)
New Jersey 1-6926 22-1454160
(STATE OF COMMISSION FILE NUMBER IRS EMPLOYER
INCORPORATION) IDENTIFICATION NO.
730 Central Avenue, Murray Hill, New Jersey
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
07974
(ZIP CODE)
(908) 277-8000
(REGISTRANT'S TELEPHONE NUMBER)
<PAGE>
Item 5. Other Events
In a news release dated December 28, 1994, C. R. Bard, Inc.
announced that it plans to take an after-tax charge to 1994
fourth quarter earnings of $16.9 million or 33 cents per share
for the settlement of a lawsuit and for legal and related
expenses. The news release, issued by the Company on
December 28, 1994, is incorporated herein be reference, and is
attached hereto as Exhibit 1.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
C. R. BARD, INC.
(Registrant)
By: William C. Bopp/s/
William C. Bopp
Senior Vice President
and Chief Financial Officer
Dated: December 29, 1994
<PAGE>
Exhibit 1 C. R. Bard, Inc.
730 Central Avenue
Murray Hill, NJ 07974
News Release
Contact: E. L. Parker
Vice President and Treasurer
(908) 277-8059
BARD SETTLES LAWSUIT - TO TAKE FOURTH QUARTER CHARGE
MURRAY HILL, NJ - December 28, 1994 - C. R. Bard, Inc. (NYSE-BCR)
announced today that it plans to take an after-tax charge to 1994
fourth quarter earnings of $16.9 million or 33 cents per share for
the settlement of a lawsuit and for legal and related expenses.
The special charge will cover the settlement of a 1992 lawsuit by
the inventor of an atherectomy device which Bard is developing.
The charge will also include a provision for the anticipated future
legal costs associated with the ongoing criminal prosecution of the
six individuals indicted as a result of the Justice Department's
prior investigation into Bard's USCI division, and for other costs
related to the USCI's division. On October 14, 1993, the Company
entered into a plea agreement resolving its portion of this matter,
but the trial of the individuals has not yet been scheduled.
Bard reported earnings of $68.9 million or $1.33 per share for the
nine months ended September 30, 1994. The Company expects to
report its fourth quarter and full year 1994 results on January 26,
1995.
C. R. Bard, Inc., headquartered in Murray Hill, NJ, is a leading
multinational developer, manufacturer and marketer of health care
products.
# # # # # #
